Biotech · Private company

Bellus Health Inc. - a GSK company

Track this companyFree. Adds Bellus Health Inc. - a GSK company to your Dealase workspace and tells you when its record changes.

Clinical trials71 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline6

A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy ParticipantsPHASE1 · COMPLETED · started Jul 9, 2024ClinicalTrials.gov NCT06497517 · fetched Nov 12, 2026
A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of AgePHASE1 · COMPLETED · started Feb 2, 2024ClinicalTrials.gov NCT06222892 · fetched Nov 12, 2026
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 5, 2022ClinicalTrials.gov NCT05600777 · fetched Nov 12, 2026
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughPHASE3 · COMPLETED · started Oct 25, 2022ClinicalTrials.gov NCT05599191 · fetched Nov 12, 2026
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic DermatitisPHASE2 · COMPLETED · started Dec 9, 2020ClinicalTrials.gov NCT04693195 · fetched Nov 12, 2026
Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughPHASE2 · COMPLETED · started Dec 7, 2020ClinicalTrials.gov NCT04678206 · fetched Nov 12, 2026
A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic CoughPHASE2 · TERMINATED · started Jul 10, 2019ClinicalTrials.gov NCT03979638 · fetched Nov 12, 2026